Vaxigrip Tetra

A randomized first-in-human, Phase 1, single-center, observer-blind, active-controlled 3-arm study to evaluate the safety, tolerability, and immunogenicity of one single administration of TETRALITE, a novel adjuvanted influenza vaccine, in healthy participants aged 18 to 50 years

INfluenza VaccInation To mitigate typE 1 Diabetes (INVITED trial)

Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients

Optimizing the time of day of influenza vaccine administration in adults aged 60-85 years: A randomized controlled trial

Antibody Glycosylation dynamics After Vaccination (AGAVE)